Nomad Power Solutions, Inc. (NMAD): Operating Cash Flow
-$3.07M
Year ended 2025-12-31
-$5.46M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.07M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$3.16M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$4.29M | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$4.61M | n/m | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | -$4.14M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$2.13M | n/c | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | $1.67M | n/c | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | -$1.51M | n/m | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | -$1.41M | n/m | 2019-03-25, From 2017-01-01 |
| 2016-12-31 | -$1.68M | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$2.18M | n/m | 2017-03-29, From 2015-01-01 |
| 2014-12-31 | -$1.64M | n/m | 2016-03-28, From 2014-01-01 |
| 2013-12-31 | -$1.18M | n/m | 2015-03-27, From 2013-01-01 |
| 2012-12-31 | -$1.21M | n/m | 2014-03-21, From 2012-01-01 |
| 2011-12-31 | -$1.36M | n/m | 2013-03-15, From 2011-01-01 |
| 2010-12-31 | -$936.4K | n/a | 2012-03-29, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | -$3.07M | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$5.68M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$5.93M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$14.11M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$13.90M | n/m |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | -$2.56M | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | -$6.35M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$3.96M | n/m |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | -$7.32M | n/m |
Compare NMAD, PPCB, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗